FDA approves oral formulation of old ALS drug, giving patients new treatment option in sorely needed field

US regulators OK’ed an oral formulation of Radicava, first approved to treat ALS back in 2017 as a series of IV infusions, to treat adults with ALS, the agency announced Thursday afternoon. The decision gives patients another option for a universally fatal disease with only one other approved drug.